The investigation determined that a higher than expected free t4 (ft4) result was obtained from a patient sample when running vitros ft4 reagent on a vitros 5600 integrated system.A definitive assignable cause could not be determined with the information provided.Vitros ft4 reagent lot 5020 was not in use at the customer site and run for troubleshooting purposes only, therefore limited quality control data was available.However, all results that were obtained for this lot were within expectation, indicating that vitros ft4 lot 5020 was performing as expected.Although diagnostic precision testing was not run at the time of the event, there is no indication of an instrument malfunction as the customer continued to obtain acceptable qc results and precision sample repeats.Unexpected instrument performance is not a likely contributor to the event.Pre-analytical sample processing could not be ruled out as a contributing factor, as it was not possible to establish if the customer was following the sample collection device manufacture¿s recommendation for sample centrifugation and cellular debris, due to poor sample preparation, was possibly present in the affected sample, although this could not be confirmed.It is also unknown how the patient sample was stored between the initial and repeat testing, and an issue with the sample storage cannot be ruled out as a contributor to the event.An issue with the reagent pack in use at the time of the higher than expected patient result is not a likely issue as qc fluids were acceptable when run using the same reagent pack.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros ft4 reagent lot 5020.(b)(4).
|